AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
34,677,880
Share change
+8,804,128
Total reported value
$1,042,053,309
Put/Call ratio
113%
Price per share
$30.05
Number of holders
112
Value change
+$263,768,588
Number of buys
84
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q1 2018

As of 31 Mar 2018, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,677,880 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Sofinnova Ventures Inc, Redmile Group, LLC, Versant Venture Management, LLC, and VANGUARD GROUP INC. This page lists 112 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.